Ignite Creation Date:
2024-05-06 @ 8:26 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06381141
Status:
RECRUITING
Last Update Posted:
2024-04-24
First Post:
2024-04-02
Brief Title:
A Study of CLN-619 Anti-MICAMICB Antibody in Patients With Relapsed and Refractory Multiple Myeloma
Sponsor:
Cullinan Therapeutics Inc
Organization:
Cullinan Therapeutics Inc
Organization Data
Organization:
Cullinan Therapeutics Inc
Class:
INDUSTRY
Study ID:
CLN-619-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cullinan Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None